Goodwill and Intangible Asset Disclosure
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
The total balance of intangible assets and goodwill experienced a period of growth followed by a contraction between 2017 and 2021. The combined value peaked in 2019 at 9,285,200 thousand US dollars before declining to 7,982,400 thousand US dollars by the end of 2021. This trajectory was primarily driven by the volatility of net intangible assets, while goodwill remained relatively stagnant after an initial increase.
- Intangible Asset Components
- Completed technology represents the largest portion of the intangible asset base, maintaining a consistent valuation between 7,187,300 thousand US dollars and 7,520,000 thousand US dollars throughout the analyzed period. In contrast, in-process research and development exhibited significant volatility, peaking at 965,500 thousand US dollars in 2019 and dropping sharply to 132,700 thousand US dollars by 2021. Trademarks and trade names remained constant at 64,000 thousand US dollars for all five years.
- Amortization and Net Book Value
- A consistent upward trend is observed in accumulated amortization, which grew from 4,385,000 thousand US dollars in 2017 to 5,388,500 thousand US dollars in 2021. This steady increase, coupled with fluctuations in the cost of intangible assets, resulted in a overall decline in net intangible assets from 3,879,600 thousand US dollars in 2017 to 2,221,300 thousand US dollars in 2021.
- Goodwill Stability
- Goodwill increased substantially between 2017 and 2018, rising from 4,632,500 thousand US dollars to 5,706,400 thousand US dollars. Following this adjustment, the balance remained remarkably stable, fluctuating only marginally between 5,706,400 thousand US dollars and 5,762,100 thousand US dollars through 2021, suggesting an absence of significant new acquisitions or impairment charges during this timeframe.
The overall financial position indicates a shift where the balance sheet is increasingly dominated by goodwill rather than net intangible assets. By 2021, goodwill constituted approximately 72% of the total intangible assets and goodwill balance, compared to approximately 54% in 2017. This transition reflects a combination of steady amortization of existing technology and a lack of significant new capitalized intangible investments.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Adjustments to Financial Statements: Removal of Goodwill
Biogen Inc., Financial Data: Reported vs. Adjusted
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
An analysis of the financial position from 2017 to 2021 reveals a consistent and substantial gap between reported and adjusted figures, indicating a significant concentration of goodwill and intangible assets on the balance sheet. While reported total assets reached a peak in 2019 before declining, the adjusted figures provide a more conservative view of the company's tangible asset base and equity structure.
- Impact on Total Asset Valuation
- The removal of goodwill and intangible assets leads to a significant reduction in the total asset base across all observed years. From 2018 through 2021, the difference between reported and adjusted total assets remained relatively stable, ranging from approximately 5.7 billion USD to 5.8 billion USD. This stability suggests that while total assets fluctuated due to other operational factors, the carrying value of goodwill and intangibles remained largely unchanged during this period.
- Adjustment of Shareholders' Equity
- A corresponding reduction is observed in shareholders' equity when intangibles are removed. In 2021, the adjusted equity of 5.1 billion USD represents less than half of the reported equity of 10.9 billion USD. This indicates that a dominant portion of the reported book value is comprised of non-physical assets, which significantly alters the perceived solvency and tangible net worth of the entity.
- Analysis of Equity Volatility
- The data highlights a sharp contraction in both reported and adjusted equity between 2019 and 2020. The decline is more pronounced in the adjusted figures; adjusted equity fell from 7.6 billion USD in 2019 to 4.9 billion USD in 2020. This suggests that the reduction in equity was driven by factors affecting tangible assets or liabilities rather than impairment of goodwill, as the absolute difference between reported and adjusted equity remained constant at approximately 5.7 to 5.8 billion USD.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Adjusted Financial Ratios: Removal of Goodwill (Summary)
Biogen Inc., Financial Ratios: Reported vs. Adjusted
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
The removal of goodwill and intangible assets results in a consistent upward shift in efficiency and profitability ratios, while simultaneously increasing the calculated financial leverage. This indicates that a substantial portion of the balance sheet is comprised of non-physical assets, which serves to dilute reported performance metrics and understate the return on tangible capital.
- Asset Utilization Efficiency
- Adjusted total asset turnover is consistently higher than reported turnover across all periods, peaking at 0.71 in 2020. The persistent gap between these two metrics suggests that intangible assets are not contributing to revenue generation in a manner proportional to their balance sheet value, thereby masking the higher efficiency of the company's tangible asset base.
- Financial Leverage and Capital Structure
- An increase in financial leverage is observed when goodwill is removed, with the adjusted ratio rising from 2.38 in 2017 to a peak of 3.82 in 2020. This divergence demonstrates that the reported equity base is heavily inflated by intangible assets; excluding these assets reveals a much higher reliance on debt relative to tangible equity, which increases the perceived financial risk profile.
- Return on Equity (ROE)
- Adjusted ROE exhibits significant volatility and amplification compared to reported figures. While reported ROE peaked at 44.13% in 2019, the adjusted ROE reached a high of 81.01% in 2020. The substantial premium in the adjusted metric underscores that the company generates a significantly higher return on its tangible equity than is apparent in the standard financial reporting.
- Return on Assets (ROA)
- A similar pattern is evident in ROA, where adjusted values consistently exceed reported values. Adjusted ROA peaked at 27.42% in 2019, compared to a reported 21.62%. The general decline in both reported and adjusted ROA during 2021 indicates a broad reduction in profitability relative to assets, although the adjusted metric continues to provide a more optimistic view of the earning power of physical assets.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
2021 Calculations
1 Total asset turnover = Revenue ÷ Total assets
= 10,981,700 ÷ 23,877,300 = 0.46
2 Adjusted total asset turnover = Revenue ÷ Adjusted total assets
= 10,981,700 ÷ 18,116,200 = 0.61
An analysis of the asset base and turnover ratios from 2017 to 2021 reveals a period of expansion followed by a contraction, with a consistent performance gap between reported and adjusted metrics due to the presence of intangible assets and goodwill.
- Asset Base Trends
- Reported total assets exhibited a growth trend from 2017 to 2019, increasing from US$ 23.65 billion to a peak of US$ 27.23 billion. This was followed by a decline in 2020 and 2021, ending the period at US$ 23.88 billion. Adjusted total assets followed a nearly identical trajectory, peaking in 2019 at US$ 21.48 billion and declining to US$ 18.12 billion by 2021. The persistent difference between reported and adjusted totals underscores a significant allocation of capital toward intangible assets.
- Reported Total Asset Turnover
- The reported asset turnover ratio remained relatively stable between 2017 and 2020, fluctuating within a narrow range of 0.52 to 0.55. However, a sharp decline occurred in 2021, where the ratio dropped to 0.46, indicating a reduction in the efficiency of total assets in generating revenue during the final year of the period.
- Adjusted Total Asset Turnover
- The adjusted total asset turnover was consistently higher than the reported ratio across all five years, ranging from a low of 0.61 in 2021 to a peak of 0.71 in 2020. The higher values in the adjusted ratio demonstrate that when goodwill and intangible assets are excluded from the denominator, the company demonstrates a higher rate of asset efficiency. Similar to the reported metric, the adjusted turnover experienced a notable decrease in 2021.
- Comparative Efficiency Analysis
- The variance between the reported and adjusted turnover ratios highlights the impact of non-physical assets on operational metrics. The adjusted ratios provide a more optimistic view of asset productivity, suggesting that the tangible asset base is utilized more intensively than the total asset base implies. The synchronized decline in both ratios in 2021 suggests an overall decrease in revenue generation relative to the asset base, regardless of whether intangible assets are considered.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
2021 Calculations
1 Financial leverage = Total assets ÷ Total Biogen Inc. shareholders’ equity
= 23,877,300 ÷ 10,896,200 = 2.19
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted total Biogen Inc. shareholders’ equity
= 18,116,200 ÷ 5,135,100 = 3.53
An analysis of the financial position from 2017 to 2021 reveals a consistent divergence between reported and adjusted financial metrics, indicating a significant presence of intangible assets and goodwill on the balance sheet. While reported assets and equity show moderate fluctuations, the adjusted figures highlight a more volatile capital structure and a higher underlying risk profile.
- Asset and Equity Trends
- Reported total assets peaked in 2019 at 27.23 billion USD before declining to 23.88 billion USD by 2021. The adjusted total assets followed a similar trajectory but remained consistently lower, ending the period at 18.12 billion USD. A more pronounced contraction is observed in shareholders' equity; reported equity fell from a peak of 13.34 billion USD in 2019 to 10.90 billion USD in 2021. However, adjusted equity experienced a more severe decline, dropping from 7.98 billion USD in 2017 to 5.14 billion USD in 2021, with a sharp reduction occurring between 2019 and 2020.
- Reported Financial Leverage
- The reported financial leverage ratio exhibited a gradual upward trend from 1.88 in 2017 to a peak of 2.30 in 2020, before slightly correcting to 2.19 in 2021. This indicates a moderate increase in the company's reliance on debt relative to its reported equity base over the five-year period.
- Adjusted Financial Leverage
- The adjusted financial leverage ratio provides a more stringent view of solvency by removing intangible assets. This ratio was consistently higher than the reported leverage throughout the period. It rose from 2.38 in 2017 to 2.83 in 2019, followed by a substantial spike to 3.82 in 2020. Although it decreased to 3.53 in 2021, the ratio remained significantly elevated compared to the start of the period.
- Comparative Risk Analysis
- The widening gap between reported and adjusted leverage ratios underscores the impact of intangible assets on the perceived financial stability of the organization. The sharp increase in adjusted leverage during 2020 suggests that the reduction in equity had a disproportionately large effect on the company's adjusted solvency position, indicating a heightened sensitivity to equity volatility when non-physical assets are excluded from the calculation.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
2021 Calculations
1 ROE = 100 × Net income attributable to Biogen Inc. ÷ Total Biogen Inc. shareholders’ equity
= 100 × 1,556,100 ÷ 10,896,200 = 14.28%
2 Adjusted ROE = 100 × Net income attributable to Biogen Inc. ÷ Adjusted total Biogen Inc. shareholders’ equity
= 100 × 1,556,100 ÷ 5,135,100 = 30.30%
An analysis of the financial performance from 2017 to 2021 reveals a significant divergence between reported and adjusted figures, primarily driven by the exclusion of goodwill and intangible assets from the equity base. The removal of these assets consistently results in a lower equity denominator, which substantially amplifies the return on equity (ROE) metrics.
- Shareholders' Equity Trends
- Reported shareholders' equity exhibited modest growth from 2017 to 2019, peaking at US$ 13.34 billion, followed by a sharp contraction to US$ 10.70 billion in 2020. Adjusted shareholders' equity followed a similar pattern but maintained a lower valuation, dropping from US$ 7.98 billion in 2017 to US$ 5.14 billion by 2021. The gap between reported and adjusted equity remained relatively stable between 2018 and 2021, suggesting a consistent level of goodwill and intangible assets held on the balance sheet during this period.
- Comparative ROE Performance
- A consistent premium is observed in adjusted ROE compared to reported ROE across all analyzed years. Reported ROE climbed from 20.13% in 2017 to a peak of 44.13% in 2019, before declining to 14.28% in 2021. In contrast, adjusted ROE experienced a more aggressive ascent, peaking at 81.01% in 2020. This indicates that when intangible assets are removed, the efficiency of the core tangible equity base appears significantly higher.
- Analysis of the 2021 Contraction
- A sharp synchronized decline in both reported and adjusted ROE is evident in 2021. While shareholders' equity remained relatively stable between 2020 and 2021, the reported ROE fell by 23.11 percentage points and the adjusted ROE fell by 50.71 percentage points. This suggests a substantial decrease in net income during the final year of the period, which impacted the return metrics regardless of the equity adjustment applied.
- Impact of Asset Adjustments
- The disparity between the two ROE metrics highlights the influence of intangible assets on the company's financial profile. The fact that adjusted ROE was more than double the reported ROE in 2020 (81.01% vs 37.39%) underscores how the inclusion of goodwill suppresses the reported return, masking the higher profitability generated by the company's tangible asset base.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
2021 Calculations
1 ROA = 100 × Net income attributable to Biogen Inc. ÷ Total assets
= 100 × 1,556,100 ÷ 23,877,300 = 6.52%
2 Adjusted ROA = 100 × Net income attributable to Biogen Inc. ÷ Adjusted total assets
= 100 × 1,556,100 ÷ 18,116,200 = 8.59%
An analysis of the asset base and return on assets (ROA) reveals a cyclical trend characterized by growth through 2019 followed by a notable contraction through 2021. The consistent variance between reported and adjusted figures underscores the significant impact of goodwill and intangible assets on the overall financial structure.
- Asset Base Trends
- Reported total assets grew from 23.65 billion US$ in 2017 to a peak of 27.23 billion US$ in 2019, before declining to 23.88 billion US$ by 2021. Adjusted total assets followed a similar trajectory, peaking at 21.48 billion US$ in 2019 and contracting to 18.12 billion US$ by 2021. The gap between reported and adjusted assets remained substantial throughout the period, indicating a high proportion of non-physical assets on the balance sheet.
- ROA Performance and Volatility
- Profitability relative to assets experienced a sharp increase between 2017 and 2019. Reported ROA rose from 10.73% to 21.62%, while adjusted ROA climbed from 13.35% to 27.42%. Following the 2019 peak, both metrics declined significantly, with reported ROA falling to 6.52% and adjusted ROA falling to 8.59% by the end of 2021.
- Comparative Impact of Asset Adjustments
- Adjusted ROA remained consistently higher than reported ROA in every analyzed year. This indicates that the removal of goodwill and intangible assets from the denominator results in a higher perceived efficiency of asset utilization. The positive variance between the two ratios peaked in 2019 at 5.8 percentage points, suggesting that the operational returns were strongest relative to the tangible asset base during that period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?